期刊文献+

神经肽Y、维拉帕米对大鼠心肌细胞肥大的影响 被引量:5

The Effect of Neuropeptide Y,Verapamil on Cardiomyocyte Hypertrophy in Rats
下载PDF
导出
摘要 通过测定培养的心肌细胞~3H-leucine(~3H-亮氨酸)掺入率和膜片钳全细胞记录方法记录Ca^(2+)电流(I_(ca)),研究神经肽Y(NPY)、维拉帕米对大鼠心肌细胞肥大的影响。结果:0.1μmol/L NPY促使培养的心肌细胞~3H-leucine掺入率增大,达(136.0±4.4)min^(-1),与对照组(91.0±4.O)min^(-1)相比,差异有显著性意义(p<0.01)。10nmol/L维拉帕米与NPY共同作用于心肌细胞24h,可使NPY促~3H-leucine掺入率增大的作用受到抑制(P<0.01)。NPY可显著增大心肌细胞I_(ca),为(12.0±3.1)pA,与对照组(5.5±2.4)pA比较,差异有显著性意义(P<0.01)。结论:NPY促使培养的心肌细胞蛋白质合成率增大的作用可被维拉帕米阻断,而NPY增加细胞内游离钙,触发心肌蛋白质合成增加,可能是促进心肌肥大的机制之一。 In order to study the effect of neuropeptide Y (NPY).verapamil on cardiomyocyte hypertrophy, the patch clamp technique was employed to detect the current density of calcium channel and 3H-leucine in-corporation. 0. 1 mol/L NPY could increase the cultured myocyte 3 H-leucine incotpotation up to (136. 0i 4.4) min,with the difference being significant (P<0. 01) as compared with the control (91. 0?. 0) min. Under the same condition,10 nmol/L verapamil and NPY were incubated together with myocytes for 24 h, the NPY-promoted increase of 3H-lecucine incorporation was inhibited (P><0. 01 ). The myocyte cur-rent was obviously increased by NPY to (12. 0?. 1) pA as compared with the control (5. 5?. 4) pA (P< 0.01). It was concluded that NPY could stimulate the protein synthesis of the cultured myocytes, which could be antagonized by verapamil. NPY could increase the calcium current and trigger the myocyte protein synthesis,which might be one of the mechanisms of myocardium hypertrophy.
出处 《同济医科大学学报》 CSCD 1998年第5期382-384,共3页 Acta Universitatis Medicinae Tongji
基金 国家自然科学基金资助项目(No.39070408)
关键词 神经肽Y 维拉帕米 心肌细胞肥大 neuropeptide Y verapami myocardium hypertrophy
  • 相关文献

参考文献4

二级参考文献1

  • 1Gu J,Histochem Cytochem,1984年,32卷,467页

共引文献11

同被引文献47

  • 1Zoccali C,Mallamaci F,Tripepi G .Neuropeptide Y,left ventricular mass and function in patients with end stage renal disease[J].J Hypertens,2003,21(7):1355.
  • 2Balasubramaniam A.Clinical potentials of neuropeptide Y family of hormones[J].Am J Surg,2002,183(4):430.
  • 3Pellieux C,Sauthier T,Domenighetti A Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen - activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptors[J].Proc Natl Acad Sci U S A,2000,97(4):1595.
  • 4Gullestad L,Aass H,Ross H,Ueland T.Neuropeptide Y receptor 1 (NPY-Y1) expression in human heart failure and heart transplantation[J].J Auton Nerv Syst,1998,70(1-2):84.
  • 5Jonsson-Rylander AC,Nordlander M,Svindland A.Distribution of neuropeptide Y Y1 and Y2 receptors in the postmortem human heart[J].Peptides,2003,24(2):255.
  • 6Jacques D,Sader S,El-Bizri N .Neuropeptide Y induced increase of cytosolic and nuclear Ca2+ in heart and vascular smooth muscle cells.Can J Physiol Pharmacol,2000,78(2):162.
  • 7Protas L,Barbuti A,Qu J.Neuropeptide Y is an essential in vivo developmental regulator of cardiac ICa,L[J].Circ Res,2003,93(10):972.
  • 8Minsheng Chen,Xiaoyun Li,Qi Dong.Neuropeptide Y induces cardiomyocyte hypertrophy via calcineurin signaling in rats[J].Regulatory Peptides,2005,(125):9.
  • 9Pheng LH,Regoli D.Receptors for NPY in peripheral tissues bioassays[J].Life Sci,2000,67(8):847.
  • 10Jacques D,Sader S,Perreault C.Presence of neuropeptide Y and the Y1 receptor in the plasma membrane and nuclear envelope of human endocardial endothelial cells: modulation of intracellular calcium[J].Can J Physiol Pharmacol,.2003,81(3):288.

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部